Tejara Capital’s Immunovant IMVT Stock Holding History

Tejara Capital’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-84,394	Closed	-$1.35M	–	63
2025 Q2	$1.35M	Buy	84,394 +30,604	+57%	+$463K	0.63%	46
2025 Q1	$919K	Buy	+53,790	New	+$1.13M	0.35%	62
2024 Q3	–	Sell	-55,210	Closed	-$1.46M	–	66
2024 Q2	$1.46M	Buy	+55,210	New	+$1.57M	0.53%	44

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Tejara Capital's IMVT Position: Q3 2025 in Review

Tejara Capital sold out of Immunovant (IMVT) in Q3 2025, closing a stake of 84,394 shares — an estimated $1.35M sold.

Tejara Capital first reported a position in IMVT in Q2 2024 and held it in 3 quarters. The position peaked at $1.46M in Q2 2024. 186 funds tracked by Wall St. Rank hold IMVT as of Q3 2025.

Tejara Capital reported no remaining Immunovant position as of Q3 2025 after selling out during the quarter.
Tejara Capital sold 84,394 Immunovant shares in Q3 2025, an estimated $1.35M.
Tejara Capital first reported a position in Immunovant in Q2 2024 and held it in 3 quarters.
Tejara Capital's Immunovant position peaked at $1.46M in Q2 2024.
186 funds tracked by Wall St. Rank held Immunovant as of Q3 2025.

Based on Tejara Capital's 13F filing for Q3 2025, filed 4 Nov 2025.